U.S. Rapid Pathogen Detection Diagnostics Market Size & Outlook

Name: U.S. Rapid Pathogen Detection Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The rapid pathogen detection diagnostics market in the United States is expected to reach a projected revenue of US$ 9,672.0 million by 2033. A compound annual growth rate of 3.8% is expected of the United States rapid pathogen detection diagnostics market from 2025 to 2033.

Clinical Diagnostics
- In Vitro Diagnostics
  - Rapid Pathogen Detection Diagnostics Market Outlook

U.S. rapid pathogen detection diagnostics product outlook (Revenue, USD million, 2021-2033)
- Rapid Test Kits
- Consumables and Reagents
- Instruments
- Software & Connectivity
U.S. rapid pathogen detection diagnostics technology outlook (Revenue, USD million, 2021-2033)
- Nucleic Acid Amplification Tests (NAAT)
- Immunoassays
- Biosensors, Microfluidics & Lab-on-Chip
- Next-Generation Sequencing & Rapid Genotyping
- Others (CRISPR) Technology
U.S. rapid pathogen detection diagnostics application outlook (Revenue, USD million, 2021-2033)
- Clinical Diagnostics
  - Respiratory Infections
  - Sexually Transmitted Infections (STIs)
  - Bloodborne & Hepatic Infections
  - Gastrointestinal Pathogens
  - Tropical & Vector-Borne Diseases
  - Others
- Public-health Surveillance & Outbreak Response
- Food Safety & Environmental Monitoring
- Others Application
U.S. rapid pathogen detection diagnostics end use outlook (Revenue, USD million, 2021-2033)
- Hospitals & Clinical Labs
- Point-of-Care
- Public-health Labs
- Food Testing Labs
- Others

U.S. Rapid Pathogen Detection Diagnostics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!